ANTI-AGEING 45
Inflammasomes: key to the engine of skin inflammaging
n James V. Gruber, PhD – BotanicalsPlus, US
In 2002, Martinon et al., described the discovery of the Nod-Like Receptor Protein (NLRP) Inflammasome Complexes and in 2009 the same group recognised more fully the importance of these critical sentinel complexes in the body’s inflammatory response that they labelled them: “the guardians of the body”.1,2
In 2008, Faustin
et al., recognised that skin cells, like keratinocytes and fibroblasts, responded to UV energy by activating the NLRP Inflammasome Complex.3
This directly linked
the activity of the skin’s two primary cell types to a direct response, outside of the normal dendritic cellular response, to the threat of UV energy. More recently, Li et al., reported that NLRP inflammasomes are activated in human sebocytes directly by exposure to Propionibacterium acnes.4
This study directly
links the impact of the skin’s microbiome to a microorganism that can become pathogenic. In 2011, Dayan and Wertz published the book Innate Immune System of Skin and Oral Mucosa. Nowhere within the chapters of this book was there mentioned the critical element of the skin’s innate immune response through the NLRP Inflammasome pathways.5
This reflects the fact that the link
between skin health and the NLRP Inflammasomes was not apparent even though it had been discovered in 2008 that both keratinocytes and fibroblasts expressed these unique inflammatory complexes. To date, studies have looked at the role of the NLRP Inflammasomes in skin health through their action in keratinocytes.6,7 These recent discussions are focused on determining if it is the NLRP1 or NLRP3 inflammasomes that are most responsible for skin health. This paper will discuss our recent work with a new, rapid bioluminescent assay that allows for examination of the release of active Caspase-1 from NLRP-inflammasome activated Normal Human Epidermal Keratinocytes (NHEK). Early discussion of this work has appeared previously.8-10
This
paper will help to bring these earlier discussions into a more practical and pragmatic discussion on the role of inflammation in skin ageing and health.
April 2020 Abstract
Regardless of the steps people take to fight the ageing process, we all continue to age. Our skin becomes the most predominately visible cue of the ageing process. Formation of wrinkles, sagging skin, age spots, thinning and similar changes become the hallmarks of the ageing process. The term “inflammaging” has been coined to describe the process of ageing that is driven through inflammatory pathways. While numerous aspects of skin inflammation have been explored, it is curious that, to date, little has been described about one of the most fundamental pathways of skin inflammation signalling and response; Inflammasomes. This paper will describe recent studies we have undertaken looking at how Nod-Like Receptor Protein (NLRP) Inflammasome Complexes form as a result of exogenous contact with various Danger- Associated Molecular Patterns (DAMPs) and Pathogen-Associated Molecular Patterns (PAMPs) and how, after forming, these critical inflammation sentinels release Caspase-1 which commences a powerful pattern of downstream inflammation responses that leads to healing and, in some cases, over-healing. The link between the formation of NLRP Inflammasomes and such critical skin health responses will be explored as will the link between formation of Inflammasome expressed Caspase-1 and such important skin maladies as acne, rosacea, dandruff, atopic dermatitis, psoriasis, and skin inflammaging will be discussed.
n 3 hours post stress n 20 hours post stress 0.3000 0.2500 0.2000 0.1500 * 0.1000 0.0500 0.0000
Non-UVB Exposed
15 mJ/cm2 30 mJ/cm2 Treatment
Figure 1: Influence of increasing UVB dose exposures on Caspase-1 expression in NHEKs. Asterisks indicate statistical significance (p≤0.05).
Methods
The methods employed to examine release of active Caspase-1 in activated NHEKs have been fully described in previous publications.9,10
Briefly, keratinocyte activation was achieved by treating NHEKs
with UVB, ATP, Nigericin and Urban Dust to activate the cells’ NLRP inflammasomes. Active Caspase-1 measurement was tested at 3 hours and 20 hours after exposure to the inflammasome activators employing the Promega Caspase-Glo 1 Inflammasome
PERSONAL CARE EUROPE 45 mJ/cm2 60 mJ/cm2 *
Caspase-1 Activation (LUM)
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196
